Patient-Centered Anticoagulation Self-Monitoring in Minority Patients

Completed · Not applicable

Conditions studied: Thromboembolism, Blood Coagulation Disorders, Cardiovascular Disease, Vascular Disease

In brief

The purpose of this study is to demonstrate the feasibility and effectiveness of anticoagulation self-monitoring coupled with an educational intervention in a minority underserved population.

Key facts

Study ID

NCT02776566

Run by

University of Illinois at Chicago

People needed

86

Starts

2016-01-01

Expected to finish

2019-02-01

Last updated by the study team

2020-08-17

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• > 21 years of age
• African American or Hispanic
• English speaking
• Has been on warfarin therapy > 3 months
• Plan to be on warfarin therapy > 12 months
• Willing ( or caregiver be willing) to do self-monitoring
• Willing to be randomized

You may not qualify if…

• Lack of access to a telephone
• Moderate to severe dementia (if lacks caregiver)
• Severe hearing impairment ( if lacks caregiver)
• Blindness ( if lacks caregiver)
• Life expectancy < 6 months
• Antiphospholipid antibody syndrome

Where it is running

• University of Illinois at Chicago — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.